|
Volumn 15, Issue 4, 2016, Pages 224-225
|
Patent watch: Modulating the human microbiome with live biotherapeutic products: Intellectual property landscape
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LIVE BIOTHERAPEUTIC PRODUCT;
NATURAL PRODUCT;
PROBIOTIC AGENT;
UNCLASSIFIED DRUG;
CARDIOVASCULAR DISEASE;
CLOSTRIDIUM DIFFICILE INFECTION;
CONNECTIVE TISSUE DISEASE;
DENTAL CARIES;
DIGESTIVE SYSTEM FUNCTION DISORDER;
DRUG INDUSTRY;
DYSBIOSIS;
FECAL MICROBIOTA TRANSPLANTATION;
FOOD INDUSTRY;
HUMAN;
IMMUNOPATHOLOGY;
INFECTION;
INFLAMMATORY DISEASE;
KIDNEY DISEASE;
MENTAL DISEASE;
METABOLIC DISORDER;
MICROBIOME;
MOUTH DISEASE;
NEOPLASM;
NEUROLOGIC DISEASE;
NONHUMAN;
NOTE;
PATENT;
PRIORITY JOURNAL;
SKIN DISEASE;
VAGINITIS;
BIOLOGICAL THERAPY;
MEDICOLEGAL ASPECT;
MICROBIOLOGY;
MICROFLORA;
PROCEDURES;
STANDARDS;
TRENDS;
BIOLOGICAL THERAPY;
DYSBIOSIS;
HUMANS;
INTELLECTUAL PROPERTY;
LEGISLATION, MEDICAL;
MICROBIOTA;
PATENTS AS TOPIC;
|
EID: 84962376125
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd.2016.48 Document Type: Note |
Times cited : (12)
|
References (0)
|